ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy

ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is the most frequently reported adverse effect of oxaliplatin. In this study, we set out to evaluate the role of the panaceo-micro-activation (PMA) zeolite in the reduction of the incidence of CIPN and hematological and liver toxicity. The possible i...

Full description

Bibliographic Details
Main Authors: Maria Giuseppa Vitale, Carmela Barbato, Anna Crispo, Francesco Habetswallner, Bernardo Maria De Martino, Ferdinando Riccardi, Angela Maione, Sandra Eisenwagen, Giovanna Vitale, Giacomo Cartenì
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Molecules
Subjects:
oxaliplatin
PMA-zeolite (clinoptilolite)
chemotherapy-induced peripheral neuropathy
liver toxicity
hematological toxicity
cancer
Online Access:https://www.mdpi.com/1420-3049/25/10/2297

Internet

https://www.mdpi.com/1420-3049/25/10/2297

Similar Items